The following questions provide general scientific and product information about PT-141and the analytical documentation associated with Whitey’s Peps research materials.
PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist that has been studied primarily in relation to sexual function. Research has examined its effects on sexual desire, sexual arousal, and erectile response.
Research has investigated PT-141 in relation to sexual desire, sexual arousal, and erectile function. Human studies have included research involving women with reduced sexual desire as well as studies examining erectile responses in men.
PT-141 acts on melanocortin receptors in the central nervous system. Research suggests that activation of melanocortin signaling can influence neural pathways involved in sexual motivation, arousal, and erectile responses.
Yes. Clinical research has investigated bremelanotide in premenopausal women with acquired, generalized hypoactive sexual desire disorder. Studies have examined changes in sexual desire and associated distress under controlled clinical conditions.
Yes. Human research has investigated PT-141 in men, including studies examining erectile response. Experimental studies have reported increased erectile activity compared with placebo under the conditions studied.
Where applicable, independent laboratory documentation may provide information about product identity, purity, and other analytical characteristics of a tested batch. Analytical results apply only to the specific sample or batch identified in the applicable laboratory documentation.